Cho, Yong Woo Kim, Kwangmyeung Park, Kinam Kwon, Ick Chan 2024-01-20T09:02:40Z 2024-01-20T09:02:40Z 2021-09-02 2014-09 1598-5032 https://pubs.kist.re.kr/handle/201004/126424 Molecular imaging aims to visualize biological processes in a living system at a molecular or cellular level while drug delivery systems (DDS) aim to deliver drugs to specific targets of tissues or organs at a controlled rate. Molecular imaging and DDS, seemingly two different subjects, however, are not completely separate. They share overlapped conceptual and technological spectra. To visualize molecular events in body molecular imaging requires delivery of imaging probes to specific targets, which has been the main technology developed in DDS for decades. Simply replacing drugs in targeted therapeutic DDS with imaging probes turns the whole system to targeted imaging system for diagnosis of diseases. Integrating imaging probes into therapeutic DDS is a starting point for theragnotics, therapy, and diagnosis performed simultaneously with one agent. Key DDS technologies applied to molecular imaging have played an important role in advances of molecular imaging. We here briefly discuss molecular imaging in the aid of drug delivery technology, with an emphasis on theragnotics of tumors. English POLYMER SOC KOREA CHITOSAN NANOPARTICLES COPOLYMERS N-(2-HYDROXYPROPYL)METHACRYLAMIDE VASCULATURE THERAPY PEPTIDE Molecular imaging in the aid of drug delivery technology Article 10.1007/s13233-014-2127-5 1 MACROMOLECULAR RESEARCH, v.22, no.9, pp.926 - 931 MACROMOLECULAR RESEARCH 22 9 926 931 scie scopus kci ART001913963 000342414100002 2-s2.0-84918767503 Polymer Science Polymer Science Review CHITOSAN NANOPARTICLES COPOLYMERS N-(2-HYDROXYPROPYL)METHACRYLAMIDE VASCULATURE THERAPY PEPTIDE molecular imaging drug delivery system theragnostics tumor nanomedicine